RxISK

Making Medicines Safer for All of Us

Drug Search by Year (Detail)

Side effect search by year (detail)

Drug:

Reaction: DERMATITIS ATOPIC

20260101 - 20261231

No. 1 - 100

Next page: 2 next page>>
No.
safetyreportid
occurcountry
patientonsetage
patientsex 1:M 2:F
Adverse reaction
Drug (openfda.generic_name, medicinalproduct)
1
26940242
US
 11 1
Dermatitis atopic,
DUPILUMAB,
2
26940255
US
 2
Dermatitis atopic, Pruritus, Dry skin,
DUPILUMAB, EPINEPHRINE, CRISABOROLE,
3
26940445
US
 29 2
Dermatitis atopic,
DUPILUMAB,
4
26940817
US
 2
Dermatitis atopic,
DUPILUMAB,
5
26940818
US
 2
Dermatitis atopic,
DUPILUMAB,
6
26940841
US
 36 1
Dermatitis atopic,
DUPILUMAB, DUPILUMAB,
7
26940848
US
 2
Dermatitis atopic, Skin fissures, Skin haemorrhage,
DUPILUMAB,
8
26941095
US
 36
Dermatitis atopic, Product dose omission issue,
NEMOLIZUMAB-ILTO,
9
26941306
US
 41 2
Dermatitis atopic,
DUPILUMAB,
10
26941311
US
 2
Dermatitis atopic,
DUPILUMAB,
11
26941573
US
 43
Dermatitis atopic, Device malfunction, Product dose omission issue,
NEMOLIZUMAB-ILTO,
12
26942133
US
 57 2
Dermatitis atopic, Eczema,
DUPILUMAB,
13
26942147
US
 12 2
Fear of injection, Dermatitis atopic,
DUPILUMAB,
14
26942152
US
 48 2
Dermatitis atopic,
DUPILUMAB,
15
26942443
US
 1
Rash, Discomfort, Sleep disorder due to a general medical condition, Rash macular, Dermatitis atopic,
DUPILUMAB, CETIRIZINE HYDROCHLORIDE,
16
26942448
US
 5 2
Dermatitis atopic,
DUPILUMAB,
17
26942470
US
 2
Dermatitis atopic, Exposure to allergen,
DUPILUMAB,
18
26942474
US
 13 2
Dermatitis atopic,
DUPILUMAB,
19
26942825
US
 70 2
Breast cancer, Dermatitis atopic,
DUPILUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM,
20
26942843
US
 18 1
Dermatitis atopic, Dry skin, Pruritus,
DUPILUMAB,
21
26942847
US
 1 1
Dermatitis atopic, Rash,
DUPILUMAB,
22
26942861
US
 48 2
Chronic sinusitis, Asthma, Dermatitis atopic, Product use in unapproved indication,
DUPILUMAB, DUPILUMAB, DUPILUMAB,
23
26942866
US
 20 2
Dermatitis atopic,
DUPILUMAB,
24
26943263
US
 3 1
Therapeutic response shortened, Dermatitis atopic, Sleep disorder due to a general medical condition, Irritability, Rash,
DUPILUMAB, ALBUTEROL SULFATE, CETIRIZINE HCL, CETIRIZINE,
25
26943293
US
 59 2
Dermatitis atopic,
DUPILUMAB,
26
26943301
US
 65 2
Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation,
DUPILUMAB,
27
26943579
US
 29 2
Loss of personal independence in daily activities, Dermatitis atopic, Pruritus, Burning sensation, Skin fissures, Dry skin,
DUPILUMAB,
28
26943596
US
 1
Dermatitis atopic, Pruritus, Therapeutic response shortened,
DUPILUMAB,
29
26943630
US
 34 2
Dermatitis atopic, Treatment noncompliance,
DUPILUMAB,
30
26943641
US
 70 2
Dermatitis atopic,
DUPILUMAB,
31
26943673
US
 84
Dermatitis atopic, Product dose omission issue,
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO,
32
26944141
US
 33 1
Dermatitis atopic, Pruritus, Dry skin, Skin exfoliation,
DUPILUMAB,
33
26944393
US
 2
Infection, Dermatitis atopic, Off label use,
OMALIZUMAB, OMALIZUMAB,
34
26944606
US
 45 2
Dermatitis atopic, Intentional dose omission,
DUPILUMAB,
35
26945464
US
 33 2
Dermatitis atopic, Pruritus,
DUPILUMAB, CETIRIZINE HYDROCHLORIDE,
36
26945835
US
 2
Dermatitis atopic, Dry skin, Skin fissures, Scab, Blister,
DUPILUMAB,
37
26945858
CA
 57 2
Loss of consciousness, Neuralgia, Dermatitis, Skin lesion, Pain, Skin burning sensation, Pain in extremity, Mobility decreased, Gait disturbance, Condition aggravated, Rash, Dermatitis atopic, Blister, Pain, Skin fissures, Peripheral swelling, Skin hypertrophy, Electric shock sensation,
DUPILUMAB, DUPILUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AMLODIPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM,
38
26947608
US
 59
Hypersensitivity, Dermatitis atopic, Cellulitis, Sepsis,
NEMOLIZUMAB-ILTO,
39
26947952
US
 87 2
Dermatitis atopic, Stress, Pruritus,
DUPILUMAB,
40
26934298
US
 23 2
Idiopathic urticaria, Dermatitis atopic, Pruritus,
DUPILUMAB, DUPILUMAB,
41
26934312
US
 79 2
Visual impairment, Dermatitis atopic,
DUPILUMAB,
42
26934864
US
 16 1
Dermatitis atopic,
DUPILUMAB,
43
26935581
US
 3 2
Urinary tract infection, Dermatitis atopic,
DUPILUMAB, DUPILUMAB,
44
26935619
US
 12 1
Dermatitis atopic,
DUPILUMAB, MONTELUKAST SODIUM, MONTELUKAST, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES,
45
26935890
US
 53 2
Dyshidrotic eczema, Loss of personal independence in daily activities, Dermatitis atopic, Drug ineffective,
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, DUPILUMAB,
46
26936017
US
 4 1
Dermatitis atopic, Pruritus, Dry skin, Skin exfoliation, Haemorrhage,
DUPILUMAB,
47
26936319
US
 8 2
Dermatitis atopic,
DUPILUMAB,
48
26936340
US
 61 2
Dermatitis atopic,
DUPILUMAB,
49
26936349
US
 71 2
Dermatitis atopic, Pruritus, Eye pruritus, Product dose omission in error,
DUPILUMAB,
50
26936744
US
 76 2
Dermatitis atopic, Therapeutic response decreased,
DUPILUMAB,
51
26937082
US
 17 1
Dermatitis atopic,
DUPILUMAB,
52
26937087
US
 2
Dermatitis atopic,
DUPILUMAB,
53
26937095
US
 71 2
Corneal abrasion, Pain, Sleep disorder due to a general medical condition, Dermatitis atopic, Pruritus,
DUPILUMAB,
54
26937120
US
 2
Dermatitis atopic,
DUPILUMAB, ADALIMUMAB,
55
26937514
US
 41 2
Dermatitis atopic, Therapeutic response shortened,
DUPILUMAB,
56
26937532
US
 34 2
Dermatitis atopic,
DUPILUMAB,
57
26938141
US
 14 2
Rash, Discomfort, Sleep disorder due to a general medical condition, Dermatitis atopic,
DUPILUMAB,
58
26938225
US
 2
Cholecystectomy, Dermatitis atopic,
UPADACITINIB, UPADACITINIB,
59
26938331
US
 1
Dermatitis atopic, Therapeutic response shortened,
DUPILUMAB,
60
26938332
US
 1
Dermatitis atopic,
DUPILUMAB,
61
26938528
27 2
Sunburn, Skin reaction, Skin swelling, Skin burning sensation, Pruritus, Dry skin, Erythema, Pain of skin, Discomfort, Dermatitis atopic,
BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM,
62
26939048
US
 2
Dermatitis atopic, Rash,
ABALOPARATIDE, DUPILUMAB,
63
26931744
US
 6
Pruritus, Skin mass, Hypersensitivity, Arthropod bite, Dermatitis atopic,
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO,
64
26931765
US
 56 2
Eczema, Dermatitis atopic,
DUPILUMAB,
65
26931771
US
 2
Dermatitis atopic, Rash, Inappropriate schedule of product administration,
DUPILUMAB,
66
26931772
US
 1
Dermatitis atopic, Inappropriate schedule of product administration, Paraesthesia, Peripheral swelling,
DUPILUMAB,
67
26931884
US
 8 1
Dermatitis atopic,
DUPILUMAB,
68
26931970
US
 2
Dermatitis atopic, Injection site pain,
LEBRIKIZUMAB-LBKZ,
69
26932072
US
 32 1
Dermatitis atopic, Rash erythematous, Pruritus,
DUPILUMAB,
70
26932082
US
 1
Dermatitis atopic, Drug ineffective,
DUPILUMAB, METHYLPHENIDATE HYDROCHLORIDE, DESONIDE, LEBRIKIZUMAB-LBKZ, MINOCYCLINE HYDROCHLORIDE,
71
26932094
US
 2
Dermatitis atopic,
DUPILUMAB,
72
26932101
US
 17 2
Injection site pain, Dermatitis atopic, Incorrect dose administered,
DUPILUMAB, DESONIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MOMETASONE FUROATE, MOMETASONE, MONTELUKAST SODIUM, MONTELUKAST, PIMECROLIMUS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ROFLUMILAST, CETIRIZINE HYDROCHLORIDE,
73
26932108
US
 31 1
Acne, Injection site pain, Dermatitis atopic,
DUPILUMAB,
74
26932250
US
 65 1
Dermatitis atopic,
DUPILUMAB,
75
26932262
US
 74 2
Dermatitis atopic, Pruritus, Rash, Product use in unapproved indication,
DUPILUMAB, DUPILUMAB,
76
26932309
US
 22 2
Dermatitis atopic,
DUPILUMAB,
77
26932315
US
 1
Dermatitis atopic, Intentional product misuse,
DUPILUMAB, DUPILUMAB,
78
26932325
US
 76 2
Dermatitis atopic,
DUPILUMAB,
79
26932331
US
 2
Dermatitis atopic, Inappropriate schedule of product administration,
DUPILUMAB,
80
26932333
US
 6 2
Dermatitis atopic,
DUPILUMAB,
81
26932387
US
 1
Dermatitis allergic, Dermatitis atopic,
DUPILUMAB, DUPILUMAB,
82
26932396
US
 2
Fear of injection, Injection site pain, Dermatitis atopic, Product dose omission issue,
DUPILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ESCITALOPRAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION,
83
26932402
US
 22 2
Dermatitis atopic, Skin fissures, Therapeutic response decreased,
DUPILUMAB,
84
26932409
US
 2
Dermatitis atopic, Rash macular, Inappropriate schedule of product administration,
DUPILUMAB,
85
26932437
US
 53
Dermatitis atopic,
NEMOLIZUMAB-ILTO,
86
26932473
US
 75 2
Dermatitis atopic, Pruritus, Rash, Stress,
DUPILUMAB,
87
26932477
US
 37 2
Dermatitis atopic,
DUPILUMAB,
88
26932490
US
 2
Dermatitis atopic, Rash pruritic,
DUPILUMAB,
89
26932495
US
 1 1
Dermatitis atopic,
DUPILUMAB,
90
26932496
US
 37 2
Dermatitis atopic,
DUPILUMAB,
91
26932499
US
 1
Dermatitis atopic, Therapeutic response shortened,
DUPILUMAB,
92
26932518
US
 1
Dermatitis atopic, Therapeutic response shortened,
DUPILUMAB,
93
26932578
US
 2
Dermatitis atopic, Maternal exposure during pregnancy,
DUPILUMAB,
94
26932598
US
 1 2
Dermatitis atopic, Product dose omission issue,
DUPILUMAB,
95
26932612
US
 89 2
Scab, Pruritus, Skin exfoliation, Dermatitis atopic,
DUPILUMAB, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN,
96
26932646
US
 67 2
Dermatitis atopic, Burning sensation, Pruritus,
DUPILUMAB, DEXTROAMPHETAMINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLONAZEPAM, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, FUROSEMIDE, GABAPENTIN, HYDROXYZINE, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, QUETIAPINE, TOPIRAMATE, ERGOCALCIFEROL, ZOLPIDEM TARTRATE,
97
26932662
US
 1
Dermatitis atopic, Pain, Discomfort, Product use in unapproved indication,
DUPILUMAB, DUPILUMAB,
98
26932670
US
 1
Dermatitis atopic, Drug ineffective,
DUPILUMAB, ALBUTEROL SULFATE, AMMONIUM LACTATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, EPINEPHRINE, ADRENALINUM, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, FLUTICASONE PROPIONATE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, MOMETASONE, MONTELUKAST SODIUM, MONTELUKAST,
99
26932705
US
 24 2
Dermatitis atopic,
DUPILUMAB,
100
26932708
US
 55 1
Dermatitis atopic, Dry skin,
DUPILUMAB,

disclaimer

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

terms

https://open.fda.gov/terms/

license

https://open.fda.gov/license/

last_updated

2026-07-30

Next page: 2 next page>>